What is the history of Costello Syndrome?

Costello syndrome was first identified by Dr. Jack Costello in 1971, who described two children with distinctive facial features, intellectual disability, and failure to thrive. Since its discovery, medical understanding of Costello syndrome has evolved from a clinical observation of physical traits to a precise genetic diagnosis, now known to be caused by germline mutations in the HRAS gene.

When and how was Costello syndrome first identified?

In 1971, Dr. Jack Costello, a pediatric surgeon in New Zealand, published the first report of Costello syndrome after treating two patients who shared a strikingly similar clinical presentation. At the time, the condition was described as a distinct syndrome characterized by coarse facial features, loose skin, and severe developmental delays. For decades, clinicians relied solely on these physical manifestations to identify Costello syndrome, often leading to diagnostic confusion with similar disorders like Cardio-facio-cutaneous (CFC) syndrome.

How did genetic discovery change our understanding?

The landscape of Costello syndrome shifted dramatically in 2005 when researchers identified that the condition is caused by activating mutations in the HRAS gene. This discovery placed Costello syndrome within a group of conditions known as "RASopathies." This genetic breakthrough allowed for:

• Definitive molecular diagnosis via blood testing.


• Improved screening protocols for cancer risks, particularly rhabdomyosarcoma and bladder cancer.


• A shift in focus toward targeted therapies that address the underlying Ras/MAPK pathway dysregulation.

What are the major milestones in patient advocacy?

The evolution of patient advocacy has been pivotal for families living with Costello syndrome. From the early days of isolation, the community has grown into a global network. Today, organizations like the Costello Syndrome Family Network work closely with researchers to bridge the gap between clinical data and the lived experience. Within the DiseaseMaps.org community, 13 individuals have shared their journeys, providing vital peer-to-peer support that helps navigate the complexities of managing Costello syndrome in a modern medical system.

Next steps

• Consult with a clinical geneticist to confirm a diagnosis through HRAS mutation analysis.


• Schedule regular screenings with a pediatric oncologist as recommended by current Costello syndrome surveillance guidelines.


• Connect with the DiseaseMaps.org community to share experiences and learn from other families.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Costello syndrome overview.


• Orphanet: Rare disease database entry for Costello syndrome (ORPHA208).


• OMIM (Online Mendelian Inheritance in Man): HRAS gene and Costello syndrome (Entry #218040).


• Costello Syndrome Family Network: Patient resources and clinical guidelines.